Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis

被引:2
|
作者
Sato, Y [1 ]
Kobayashi, T [1 ]
Nakatsuka, H [1 ]
Yamamoto, S [1 ]
Oya, H [1 ]
Watanabe, T [1 ]
Hatakeyama, K [1 ]
机构
[1] Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518510, Japan
关键词
shear stress; portal hypertension; portal pressure; liver regeneration; liver injury;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In this study, we investigated whether a reduction of surplus portal hypertension after a major hepatectomy by SPL (splenic arterial ligation) prevents a liver injury in cirrhotic patients with hepatocellular carcinoma. Methodology: Six hepatocellular carcinoma patients (SPL group) with liver cirrhosis (67 +/- 10 years old, ICGR(15): 21.0 +/-9.8%, T.Bil: 1.1 +/-1.2mg/dL) underwent major hepatectomy with splenic arterial ligation in order to reduce excessive portal hypertension after hepatectomy from 1998 to 2000, July. The patients (n=15, 60 +/-9 years old, ICGR(15): 11.5 +/-5.9%, T.Bil: 0.66 +/-0.15mg/dL) who underwent liver resection above subsegmentectomy in the same period (control group) served as the control for SPL group. Results: In the SPL group, the portal pressures before hepatectomy were 26 +/- 7cm H2O and those after hepatectomy were 29 +/- 6cm H2O. The portal pressure after splenic arterial ligation decreased to 24.5 +/-6.3cm H2O. The splenic tissue blood flows before SPL were 16.8 +/-5.6mL/min/100g, while those after SPL were 7.2 +/-2.2mL/min/100g. The portal pressures before hepatectomy were 17 +/- 2cm H2O and those after hepatectomy were 19 +/- 2cm H2O in the six control patients. At the peak levels of liver function after surgery, T.Bil was 2.6 +/-1.5mg/dL, GOT was 165 +/- 59 IU/L, and GPT was 107 +/- 49 IU/L. Ah patients could discharge without complications except for one case with bile leakage in SPL. At the peak levels of liver function in control group, T.Bil was 3.7 +/-1.9mg/dL, GOT was 404+/227 IU/L, and GPT was 322 +/- 171 IU/L. At the peak levels of Liver function after surgery, T.Bil was 3.4 +/-1.3mg/dL, GOT was 398 +/- 289 IU/L, and GPT was 319 +/- 220 IU/L. Conversely, there were 11 episodes of complications (11/15), including two cases of hospital death resulting from liver failure in patients who underwent right lobectomy, in the control patients. Conclusions: The decompression of surplus portal hypertension by SPL might be effective in the prevention of post hepatectomized Liver injury and the improvement of postoperative mortality and morbidity.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 45 条
  • [21] Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching
    Wang, Xiaoqiang
    Li, Yi-ran
    Shi, Yumiao
    Li, Xiaoying
    Luo, Jiamei
    Zhang, Yiqi
    Qi, Bo
    Wu, Feixiang
    Sun, Yuming
    Pan, Zhiying
    Tian, Jie
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension?
    Takamatsu, Yuichi
    Hori, Tomohide
    Machimoto, Takafumi
    Hata, Toshiyuki
    Kadokawa, Yoshio
    Ito, Tatsuo
    Kato, Shigeru
    Yasukawa, Daiki
    Aisu, Yuki
    Kimura, Yusuke
    Kitano, Taku
    Yoshimura, Tsunehiro
    AMERICAN JOURNAL OF CASE REPORTS, 2018, 19 : 137 - 144
  • [23] Inferior Right Hepatic Vein-preserving Major Right Hepatectomy for Hepatocellular Carcinoma in Patients with Significant Fibrosis or Cirrhosis
    Jiang, Chunping
    Wang, Zhongxia
    Xu, Qingxiang
    Wu, Xingyu
    Ding, Yitao
    WORLD JOURNAL OF SURGERY, 2014, 38 (01) : 159 - 167
  • [24] Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients
    Chen, Xiang
    Zou, Heng
    Xiong, Li
    Huang, Sheng-Fu
    Miao, Xiong-Ying
    Wen, Yu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [25] HUMAN EARLY LIVER REGENERATION AFTER HEPATECTOMY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: SPECIAL REFERENCE TO AGE
    Shirabe, K.
    Motomura, T.
    Takeishi, K.
    Morita, K.
    Kayashima, H.
    Taketomi, A.
    Ikegami, T.
    Soejima, Y.
    Yoshizumi, T.
    Maehara, Y.
    SCANDINAVIAN JOURNAL OF SURGERY, 2013, 102 (02) : 101 - 105
  • [26] Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study
    Víctor Molina
    Jaime Sampson-Dávila
    Joana Ferrer
    Constantino Fondevila
    Rafael Díaz del Gobbo
    David Calatayud
    Jordi Bruix
    Juan Carlos García-Valdecasas
    Josep Fuster
    Surgical Endoscopy, 2018, 32 : 2345 - 2354
  • [27] Effect of fast-track rehabilitation on liver cirrhosis patients with portal hypertension after surgical therapy
    Zhang, Xia
    Zhang, Jing
    Li, Jun
    Cui, Gang
    Li, Gang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20090 - 20094
  • [28] Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy
    Zhang, Xiao-feng
    Niu, Xiao-feng
    Li, Li-xin
    He, Xi
    Li, Zhi-jie
    Liu, Zhen-wen
    Zhang, Da-li
    Ren, Hui
    CURRENT MEDICAL RESEARCH AND OPINION, 2025, 41 (02) : 253 - 259
  • [29] Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study
    Molina, Victor
    Sampson-Davila, Jaime
    Ferrer, Joana
    Fondevila, Constantino
    Diaz del Gobbo, Rafael
    Calatayud, David
    Bruix, Jordi
    Carlos Garcia-Valdecasas, Juan
    Fuster, Josep
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (05): : 2345 - 2354
  • [30] Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension
    Wei, Jian
    Li, Honglu
    Li, Changqing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (04) : 826 - 832